Prat A - Search Results

1

Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy.

Chic N, Schettini F, Brasó-Maristany F, Sanfeliu E, Adamo B, Vidal M, Martínez D, Galván P, González-Farré B, Cortés J, Gavilá J, Saura C, Oliveira M, Pernas S, Martínez-Sáez O, Soberino J, Ciruelos E, Carey LA, Muñoz M, Perou CM, Pascual T, Bellet M, Prat A. Chic N, et al. Among authors: prat a. EBioMedicine. 2021 Jul;69:103451. doi: 10.1016/j.ebiom.2021.103451. Epub 2021 Jun 20. EBioMedicine. 2021. PMID: 34161883 Free PMC article. Clinical Trial.

2

New approaches in angiogenic targeting for colorectal cancer.

Prat A, Casado E, Cortés J. Prat A, et al. World J Gastroenterol. 2007 Nov 28;13(44):5857-66. doi: 10.3748/wjg.v13.i44.5857. World J Gastroenterol. 2007. PMID: 17990351 Free PMC article. Review.

3

A rare case of malignant solitary fibrous tumor of the spinal cord.

Muñoz E, Prat A, Adamo B, Peralta S, Ramón y Cajal S, Valverde C. Muñoz E, et al. Among authors: prat a. Spine (Phila Pa 1976). 2008 May 20;33(12):E397-9. doi: 10.1097/BRS.0b013e31817343dc. Spine (Phila Pa 1976). 2008. PMID: 18496336 Review.

4

The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2.

Prat A, Baselga J. Prat A, et al. Nat Clin Pract Oncol. 2008 Sep;5(9):531-42. doi: 10.1038/ncponc1179. Epub 2008 Jul 8. Nat Clin Pract Oncol. 2008. PMID: 18607391 Review.

5

Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels.

Prat A, Parera M, Adamo B, Peralta S, Perez-Benavente MA, Garcia A, Gil-Moreno A, Martinez-Palones JM, Baselga J, del Campo JM. Prat A, et al. Ann Oncol. 2009 Feb;20(2):294-7. doi: 10.1093/annonc/mdn601. Epub 2008 Sep 26. Ann Oncol. 2009. PMID: 18820245 Free article.

6

Mammary development meets cancer genomics.

Prat A, Perou CM. Prat A, et al. Nat Med. 2009 Aug;15(8):842-4. doi: 10.1038/nm0809-842. Nat Med. 2009. PMID: 19661985 No abstract available.

7

WITHDRAWN: Deconstructing the molecular portraits of breast cancer.

Prat A, Perou CM. Prat A, et al. Mol Oncol. 2010 Apr 14. doi: 10.1016/j.molonc.2010.04.003. Online ahead of print. Mol Oncol. 2010. PMID: 20447881 Free article. No abstract available.

8

Clinical implementation of the intrinsic subtypes of breast cancer.

Perou CM, Parker JS, Prat A, Ellis MJ, Bernard PS. Perou CM, et al. Among authors: prat a. Lancet Oncol. 2010 Aug;11(8):718-9; author reply 720-1. doi: 10.1016/S1470-2045(10)70176-5. Lancet Oncol. 2010. PMID: 20688274 No abstract available.

9

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.

Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM. Prat A, et al. Breast Cancer Res. 2010;12(5):R68. doi: 10.1186/bcr2635. Epub 2010 Sep 2. Breast Cancer Res. 2010. PMID: 20813035 Free PMC article.

10

Deconstructing the molecular portraits of breast cancer.

Prat A, Perou CM. Prat A, et al. Mol Oncol. 2011 Feb;5(1):5-23. doi: 10.1016/j.molonc.2010.11.003. Epub 2010 Nov 24. Mol Oncol. 2011. PMID: 21147047 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

905 results

Search Page